# Wecare Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wecare-medical

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.wecare-med.com
- Total disclosed funding: $0.8M
- Latest round: Angel (Sep 1, 2021)
- Investors on record: 1

## About

Established in 2021 and based in Hangzhou, China, Wecare Medical operates as a healthcare service provider that manufactures medical grade wearable devices for seizure monitoring and alerting for epilepsy disorders. It has set up a maketing center in Beijing and has cooperated with Xi'an Jiaotong University and Beijing Institute of Technology. The company has applied 17 patents and has been recognized as a National High-Tech Enterprise. The CEO, Sheng Duozheng, graduated from Xi'an Jiaotong University and has worked for GE Healthcare and iSoftStone. In January 2025, Wecare Medical closed a venture funding from Yunsong Capital.


Wecare Medical has developed and produced Biovital wristwatch, which can realize monitoring alarm and quantitative assessment of epilepsy. The wristwatch collects biomarkers that can reflect seizures such as EDA (skin electricity), SEMG (myoelectricity), gyroscope, skin temperature, heart rate, and blood oxygen. The company has also developed a digital health platform, a time-interference (TI) non-invasive deep brain neuromodulation system and non-invasive vagus nerve stimulation (tVNS) products. The digital health platform can be applied to outpatient monitoring of diseases such as epilepsy and Parkinson's disease.

The company generates revenue by developing wristband multimodal signal acquisition device, disease onset monitoring algorithm and visual data analysis management system.

## Funding rounds

- Angel, Sep 1, 2021, $0.8M — Yushan Partners

## Investors

- Yushan Partners (https://capitalatlas.ai/funds/yushan-partners) — Angel